The School of Pharmacy at the University of Wisconsin-Madison has launched a psychedelics research center going by the name ‘Transdisciplinary Center for Research in Psychoactive Substances’.
Researchers in the center, will be mandated with investigating the therapeutic potential of psychedelics like MDMA, DMT and psilocybin in treating mental conditions like post-traumatic stress disorder, major depressive disorder, anxiety and opioid addition.
Additionally, the research center will also be in charge of offering educational training for scientists and medical employees working in the psychedelics sector.
The School of Pharmacy assured that the University would take measures to make sure diversity in participants will be ensured in the studies further noting that people of color are often underrepresented in psychedelics studies.
A professor in the School of Pharmacy, Paul Hutson, says there is a significant imbalance in the number of Asian, Black, Hispanic and Native American research participants in psychedelics studies. Hutson is also a founding director of the psychedelics research center.
Hutson pointed out that the center will be focusing on looking for opportunities which will improve representation of marginalized groups, minority groups and the elderly in psychedelics studies.
